These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 25266426)

  • 21. Age and CD4 count at initiation of antiretroviral therapy in HIV-infected children: effects on long-term T-cell reconstitution.
    Lewis J; Walker AS; Castro H; De Rossi A; Gibb DM; Giaquinto C; Klein N; Callard R
    J Infect Dis; 2012 Feb; 205(4):548-56. PubMed ID: 22205102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. CD4 cell response before and after HAART initiation according to viral load and growth indicators in HIV-1-infected children in Abidjan, Côte d'Ivoire.
    De Beaudrap P; Rouet F; Fassinou P; Kouakoussui A; Mercier S; Ecochard R; Msellati P
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):70-6. PubMed ID: 18667922
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Risk of first-line antiretroviral therapy failure in HIV-infected Thai children and adolescents.
    Bunupuradah T; Sricharoenchai S; Hansudewechakul R; Klinbuayaem V; Teeraananchai S; Wittawatmongkol O; Akarathum N; Prasithsirikul W; Ananworanich J;
    Pediatr Infect Dis J; 2015 Mar; 34(3):e58-62. PubMed ID: 25478649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced thymic output is a major mechanism of immune reconstitution failure in HIV-infected patients after long-term antiretroviral therapy.
    Li T; Wu N; Dai Y; Qiu Z; Han Y; Xie J; Zhu T; Li Y
    Clin Infect Dis; 2011 Nov; 53(9):944-51. PubMed ID: 21960716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Complete immune and clinical recovery after highly active antiretroviral therapy in advanced vertically HIV-1 infected children].
    Resino S; Sánchez-Ramón S; Correa R; Navarro ML; Bellón JM; Muñoz-Fernández MA
    Med Clin (Barc); 2003 Mar; 120(11):417-20. PubMed ID: 12681220
    [TBL] [Abstract][Full Text] [Related]  

  • 26. HIV-1 RNA, CD4 T-lymphocytes, and clinical response to highly active antiretroviral therapy.
    Sterling TR; Chaisson RE; Moore RD
    AIDS; 2001 Nov; 15(17):2251-7. PubMed ID: 11698698
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The Factors Related to CD4+ T-Cell Recovery and Viral Suppression in Patients Who Have Low CD4+ T Cell Counts at the Initiation of HAART: A Retrospective Study of the National HIV Treatment Sub-Database of Zhejiang Province, China, 2014.
    He L; Pan X; Dou Z; Huang P; Zhou X; Peng Z; Zheng J; Zhang J; Yang J; Xu Y; Jiang J; Chen L; Jiang J; Wang N
    PLoS One; 2016; 11(2):e0148915. PubMed ID: 26900702
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of highly active antiretroviral therapy in HIV-infected children participating in Thailand's National Access to Antiretroviral Program.
    Puthanakit T; Oberdorfer A; Akarathum N; Kanjanavanit S; Wannarit P; Sirisanthana T; Sirisanthana V
    Clin Infect Dis; 2005 Jul; 41(1):100-7. PubMed ID: 15937769
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CD4+ cells recovery in HIV positive patients with severe immunosuppression at HAART initiation at Centre Medico-Social Cor-Unum, Kigali.
    Merci NM; Emerence U; Augustin N; Habtu M; Julie I; Angelique T; Jessica B; Cynthia A; Penda AT
    Pan Afr Med J; 2017; 26():14. PubMed ID: 28450993
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F; Mezzaroma I
    AIDS Rev; 2006; 8(2):88-97. PubMed ID: 16848276
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple CD4+ cell kinetic patterns and their relationships with baseline factors and virological responses in HIV type 1 patients receiving highly active antiretroviral therapy.
    Wu H; Connick E; Kuritzkes DR; Landay A; Spritzler J; Zhang B; Spear GT; Kessler H; Lederman MM;
    AIDS Res Hum Retroviruses; 2001 Sep; 17(13):1231-40. PubMed ID: 11559422
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunologic outcomes of antiretroviral therapy among HIV-infected Nigerian children and its association with early infant feeding and nutritional status at treatment initiation.
    Omoni AO; Christian PS; Sadoh WE; Okechukwu A; Olateju E; Omoigberale A; Blattner W; Charurat ME
    Pediatr Infect Dis J; 2013 Jul; 32(7):e291-7. PubMed ID: 23411626
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of first-line antiretroviral therapy and correlates of longitudinal changes in CD4 and viral load among HIV-infected children in Ghana.
    Barry O; Powell J; Renner L; Bonney EY; Prin M; Ampofo W; Kusah J; Goka B; Sagoe KW; Shabanova V; Paintsil E
    BMC Infect Dis; 2013 Oct; 13():476. PubMed ID: 24119088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term survival and immuno-virological response of African HIV-1-infected children to highly active antiretroviral therapy regimens.
    Rouet F; Fassinou P; Inwoley A; Anaky MF; Kouakoussui A; Rouzioux C; Blanche S; Msellati P;
    AIDS; 2006 Nov; 20(18):2315-9. PubMed ID: 17117017
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Viral load predicts new world health organization stage 3 and 4 events in HIV-infected children receiving highly active antiretroviral therapy, independent of CD4 T lymphocyte value.
    Oliveira R; Krauss M; Essama-Bibi S; Hofer C; Robert Harris D; Tiraboschi A; de Souza R; Marques H; Succi R; Abreu T; Della Negra M; Hazra R; Mofenson LM; Siberry GK;
    Clin Infect Dis; 2010 Dec; 51(11):1325-33. PubMed ID: 21039218
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Virologic and immunologic response to antiretroviral therapy and predictors of HIV type 1 drug resistance in children receiving treatment in Abidjan, Côte d'Ivoire.
    Adjé-Touré C; Hanson DL; Talla-Nzussouo N; Borget MY; Kouadio LY; Tossou O; Fassinou P; Bissagnene E; Kadio A; Nolan ML; Nkengasong JN
    AIDS Res Hum Retroviruses; 2008 Jul; 24(7):911-7. PubMed ID: 18593341
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Timing of antiretroviral therapy initiation and its impact on disease progression in perinatal human immunodeficiency virus-1 infection.
    Sturt AS; Halpern MS; Sullivan B; Maldonado YA
    Pediatr Infect Dis J; 2012 Jan; 31(1):53-60. PubMed ID: 21979798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. An optimal body mass index range associated with improved immune reconstitution among HIV-infected adults initiating antiretroviral therapy.
    Koethe JR; Jenkins CA; Shepherd BE; Stinnette SE; Sterling TR
    Clin Infect Dis; 2011 Nov; 53(9):952-60. PubMed ID: 21946189
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Interleukin-7 and immunologic failure despite treatment with highly active antiretroviral therapy in children perinatally infected with HIV-1.
    Chiappini E; Galli L; Azzari C; de Martino M
    J Acquir Immune Defic Syndr; 2003 Aug; 33(5):601-4. PubMed ID: 12902804
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potent and sustained antiviral response of raltegravir-based highly active antiretroviral therapy in HIV type 1-infected children and adolescents.
    Briz V; León-Leal JA; Palladino C; Moreno-Perez D; de Ory SJ; De José MI; González-Tomé MI; Martín CG; Pocheville I; Ramos JT; Leal M; Muñoz-Fernández MÁ
    Pediatr Infect Dis J; 2012 Mar; 31(3):273-7. PubMed ID: 22330165
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.